More than 60 attendees across China and around the globe came to this session to discuss advances in clinical and basic research of osteoarthritis (OA). The scientific programme included presentations given by prestigious Chinese professors as well as 3-minute speech contests delivered by 12 excellent young investigators in the field of OA. The presentation topics ranged from epidemiological and etiological research to latest developments in diagnosis and treatment of OA.
The editors of the journal Osteoarthritis and Cartilage announce a request for original research papers for a special themed issue addressing “Innate Immunity in OA”.
The Pre-Competitive Consortium for OA (PCCOA) was created by OARSI more than a decade ago in response to a Federal Register Notice seeking a critical appraisal on a number of questions that would help to inform the updating of the 1999 guidance for Clinical Development Programs for the Treatment and Prevention OA. Subsequently in 2016, OARSI submitted a White Paper to the FDA providing a comprehensive review and rationale...
Join the meeting by Webex Click here for more information.
By Various
~The Pre-Competitive Consortium for Osteoarthritis, an initiative of the Osteoarthritis Research Society International, submitted a White Paper...
Tags: White Paper, Serious Disease, FDA
By Multiple Authors
For the first time, OARSI has developed treatment guidelines tailored to different types of patients with osteoarthritis (OA) of the knee. These...
Tags: Patient Summary, Guidelines, Knee Osteoarthritis
2 weeks 1 day ago.